Cartesian Therapeutics, Inc.RNAC
What Cartesian Therapeutics, Inc. does.
The Company (formerly known as Selecta Biosciences, Inc., or Selecta) was incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland. On November 13, 2023, the Company and the Delaware corporation which, immediately prior to the Merger (as defined below), was known as Cartesian Therapeutics, Inc., or Old Cartesian, entered into an Agreement and Plan of Merger, or the Merger Agreement, by and among the Company, Sakura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company, or First Merger Sub, Sakura Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company, or Second Merger Sub, and Old Cartesian. Pursuant to the Merger Agreement, and simultaneously with execution thereof, (i) First Merger Sub merged with and into Old Cartesian, pursuant to which Old Cartesian was the surviving corporation, or the First Step Surviving Corporation, and became a wholly owned subsidiary of the Company, or the First Merger, and (ii) immediately following the First Merger, Old Cartesian (as the First Step Surviving Corporation) merged with and into Second Merger Sub, pursuant to which Second Merger Sub was the surviving company, or the Surviving Company, and continued under the name “Cartesian Bio, LLC”, or the Second Merger and, together with the First Merger, the Merger. In connection with the Merger and pursuant to the Merger Agreement, the Company (which was known as Selecta Biosciences, Inc. until immediately prior to the Merger) changed its corporate name to Cartesian Therapeutics, Inc.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.6M | $85.1M | $110.8M | $26.0M | $38.9M | $2.8M |
| Net income | -$68.9M | -$25.7M | $35.4M | -$219.7M | -$77.4M | -$130.3M |
| Free cash flow | $34.1M | -$61.5M | -$32.8M | -$51.4M | -$32.8M | -$79.4M |
More on RNAC.
- Cartesian Therapeutics, Inc. summary
- Cartesian Therapeutics, Inc. financial statements
- Cartesian Therapeutics, Inc. key metrics
- Cartesian Therapeutics, Inc. health scores and style box
- Cartesian Therapeutics, Inc. earnings
- Cartesian Therapeutics, Inc. dividends
- Cartesian Therapeutics, Inc. valuation
- Cartesian Therapeutics, Inc. ownership and insiders
- Cartesian Therapeutics, Inc. peers
Figures from Cartesian Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.